Financial information

The information source is the annual report of the company with business id 556713-3425

* Closing information (×1000) SEK

Fiscal year 202303 202203 (consolidated) 202103 (consolidated)
Number of months: 12 12
Turnover: 259,913 Revenue Down 409,753 Revenue Up 179,141
Financial expenses: 2,372 Revenue Down 2,874 Revenue Up 1,004
Earnings before taxes: 38,968 Revenue Up 35,965 Revenue Up 10,440
Total assets: 285,696 Revenue Up 237,888 Revenue Up 198,826
Current assets: 167,228 Revenue Up 123,452 Revenue Up 97,938
Current liabilities: 115,976 Revenue Up 98,757 Revenue Up 94,931
Equity capital: 154,753 Revenue Up 123,626 Revenue Up 91,295
Share capital: 1,308 1,308 1,308
Number of employees: 18 Revenue Up 13 Revenue Up 10

Financial ratios

Solvency: 54.2% Revenue Up 52.0% Revenue Up 45.9%
Turnover per employee: 14,440 Revenue Down 31,519 Revenue Up 17,914
Profitability: 15.0% Revenue Up 8.8% Revenue Up 5.8%
Return on equity (ROE): 25.2% Revenue Down 29.1% Revenue Up 11.4%
Current ratio: 144.2% Revenue Up 125.0% Revenue Up 103.2%
Return on assets (ROA): 14.5% Revenue Down 16.3% Revenue Up 5.8%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202303
Number of months: 12
Turnover: 259,913
Financial expenses: 2,372
Earnings before taxes: 38,968
Total assets: 285,696
Current assets: 167,228
Current liabilities: 115,976
Equity capital: 154,753
Share capital: 1,308
Number of employees: 18

Financial ratios

Solvency: 54.2%
Turnover per employee: 14,440
Profitability: 15.0%
Return on equity (ROE): 25.2%
Current ratio: 144.2%
Return on assets (ROA): 14.5%